Fusion proteins for delivery of GDNF and BDNF to the central nervous system

Details for Australian Patent Application No. 2010258052 (hide)

Owner Angiochem Inc.

Inventors Demeule, Michel; Boivin, Dominique; Castaigne, Jean-Paul

Agent Pizzeys

Pub. Number AU-A-2010258052

PCT Pub. Number WO2010/142035

Priority 61/186,246 11.06.09 US

Filing date 11 June 2010

Wipo publication date 16 December 2010

International Classifications

C07K 17/00 (2006.01) Carrier-bound or immobilised peptides

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07K 14/475 (2006.01) Peptides having more than 20 amino acids

C07K 14/81 (2006.01) Peptides having more than 20 amino acids - Protease inhibitors

C07K 19/00 (2006.01) Hybrid peptides

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

12 January 2012 PCT application entered the National Phase

  PCT publication WO2010/142035 Priority application(s): WO2010/142035

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010258055-Drill rod locking assembly

2010258051-Die tooling for extruding tubular product